Financials
Income statement
Fiscal date | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
---|---|---|---|---|
Total reported revenue | 2.9B | 2.8B | 3.1B | 3.3B |
Cost of revenue | 1.4B | 1.3B | 1.4B | 1.4B |
Gross profit | 1.6B | 1.6B | 1.7B | 1.9B |
Operating expense | ||||
Research & development | 573M | 547M | 612M | 577M |
Selling general and admin | 278M | 281M | 323M | 265M |
Other operating expenses | — | — | — | — |
Operating income | 686M | 705M | 715M | 995M |
Non operating interest income | ||||
Income | 39M | 35M | 35M | 36M |
Expense | 115M | 106M | 100M | 96M |
Other income expense | 1M | 18M | -40M | -5M |
Pretax income | 601M | 631M | 584M | 908M |
Tax provision | 116M | 130M | 77M | 173M |
Net income | 457M | 497M | 505M | 729M |
Basic EPS | 1.8 | 1.9 | 2.0 | 2.8 |
Diluted EPS | 1.8 | 1.9 | 1.9 | 2.8 |
Basic average shares | 252.4M | 253.7M | 254.3M | 254.5M |
Diluted average shares | 253.8M | 255.0M | 256.6M | 257.7M |
EBITDA | 923M | 946M | 953M | 1.2B |
Net income from continuing op. | 457M | 497M | 505M | 729M |
Minority interests | -12M | -7M | -10M | -11M |
Preferred stock dividends | — | — | — | — |